| Sources | Names Used |
|---|---|
| CTRPv2 | PRL-3 inhibitor I |
| PharmacoGx | PRL-3 Inhibitor I |
| Database | Identifier |
|---|---|
| Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
| Pubchem: | 11983303 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCFD2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | GHR | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | PROSER1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | MOSPD3 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | NYAP1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | IGSF1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | ADGRB1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | CCDC110 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BNC2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | MED31 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
